A shortage of vaccines has hit India's vaccination drive. As the drive has been opened for the 18-44 age group, the demand for the jabs has increased massively. However, only two companies are manufacturing the anti-Covid drugs. Will competitive bidding lead to price escalation? Why should states import directly and not the centre?